Cambridge, MA, United States of America

Seth C Alexander

This inventor holds 1 USPTO granted patent. Top assignee: Intellia Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seth C Alexander. Retrieved from https://idiyas.com/inventor/seth-c-alexander-22addkpl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Seth C. Alexander

Introduction

Seth C. Alexander is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the development of innovative genetic tools. His work is characterized by a commitment to advancing scientific knowledge and improving therapeutic strategies.

Latest Patents

Seth C. Alexander holds a patent titled "Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent." This patent represents a crucial advancement in the area of gene editing and therapeutic applications. He has 1 patent to his name, showcasing his innovative approach to solving complex biological problems.

Career Highlights

Seth is currently employed at Intellia Therapeutics, Inc., a leading company in the field of gene editing. His role at Intellia allows him to work on cutting-edge technologies that have the potential to transform medicine. His expertise and dedication have positioned him as a key player in the biotechnology sector.

Collaborations

Seth collaborates with various professionals in his field, including his coworker Yong Chang. Together, they work on projects that aim to push the boundaries of genetic research and therapeutic development.

Conclusion

Seth C. Alexander's contributions to biotechnology and his innovative patent work exemplify the impact of dedicated inventors in advancing science. His ongoing efforts at Intellia Therapeutics, Inc. continue to inspire progress in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…